107 related articles for article (PubMed ID: 34327899)
21. Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B.
Wang LL; Blasioli J; Plas DR; Thomas ML; Yokoyama WM
J Immunol; 1999 Feb; 162(3):1318-23. PubMed ID: 9973385
[TBL] [Abstract][Full Text] [Related]
22. Novel mode of ligand binding by the SH2 domain of the human XLP disease gene product SAP/SH2D1A.
Li SC; Gish G; Yang D; Coffey AJ; Forman-Kay JD; Ernberg I; Kay LE; Pawson T
Curr Biol; 1999 Dec; 9(23):1355-62. PubMed ID: 10607564
[TBL] [Abstract][Full Text] [Related]
23. Analysis of tyrosine phosphorylation and phosphotyrosine-binding proteins in germinating seeds from Scots pine.
Kovaleva V; Cramer R; Krynytskyy H; Gout I; Gout R
Plant Physiol Biochem; 2013 Jun; 67():33-40. PubMed ID: 23542181
[TBL] [Abstract][Full Text] [Related]
24. Protein-phosphotyrosine proteome profiling by superbinder-SH2 domain affinity purification mass spectrometry, sSH2-AP-MS.
Tong J; Cao B; Martyn GD; Krieger JR; Taylor P; Yates B; Sidhu SS; Li SS; Mao X; Moran MF
Proteomics; 2017 Mar; 17(6):. PubMed ID: 27880036
[TBL] [Abstract][Full Text] [Related]
25. Ultratrace enrichment of tyrosine phosphorylated peptides on an imprinted polymer.
Helling S; Shinde S; Brosseron F; Schnabel A; Müller T; Meyer HE; Marcus K; Sellergren B
Anal Chem; 2011 Mar; 83(5):1862-5. PubMed ID: 21306124
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of different phospho-tyrosine antibodies for label-free phosphoproteomics.
van der Mijn JC; Labots M; Piersma SR; Pham TV; Knol JC; Broxterman HJ; Verheul HM; Jiménez CR
J Proteomics; 2015 Sep; 127(Pt B):259-63. PubMed ID: 25890253
[TBL] [Abstract][Full Text] [Related]
27. Crk adaptor protein-induced phosphorylation of Gab1 on tyrosine 307 via Src is important for organization of focal adhesions and enhanced cell migration.
Watanabe T; Tsuda M; Makino Y; Konstantinou T; Nishihara H; Majima T; Minami A; Feller SM; Tanaka S
Cell Res; 2009 May; 19(5):638-50. PubMed ID: 19350053
[TBL] [Abstract][Full Text] [Related]
28. Conformationally constrained phosphotyrosyl mimetics designed as monomeric Src homology 2 domain inhibitors.
Burke TR; Barchi JJ; George C; Wolf G; Shoelson SE; Yan X
J Med Chem; 1995 Apr; 38(8):1386-96. PubMed ID: 7537333
[TBL] [Abstract][Full Text] [Related]
29. Investigation of phosphotyrosine recognition by the SH2 domain of the Src kinase.
Bradshaw JM; Mitaxov V; Waksman G
J Mol Biol; 1999 Nov; 293(4):971-85. PubMed ID: 10543978
[TBL] [Abstract][Full Text] [Related]
30. Phosphoproteomics.
Zhong J; Molina H; Pandey A
Curr Protoc Protein Sci; 2007 Nov; Chapter 24():Unit 24.4. PubMed ID: 18429323
[TBL] [Abstract][Full Text] [Related]
31. SH2 Domain Histochemistry.
Buhs S; Nollau P
Methods Mol Biol; 2017; 1555():535-545. PubMed ID: 28092054
[TBL] [Abstract][Full Text] [Related]
32. ZAP-70 binding specificity to T cell receptor tyrosine-based activation motifs: the tandem SH2 domains of ZAP-70 bind distinct tyrosine-based activation motifs with varying affinity.
Isakov N; Wange RL; Burgess WH; Watts JD; Aebersold R; Samelson LE
J Exp Med; 1995 Jan; 181(1):375-80. PubMed ID: 7528772
[TBL] [Abstract][Full Text] [Related]
33. 4'-O-[2-(2-fluoromalonyl)]-L-tyrosine: a phosphotyrosyl mimic for the preparation of signal transduction inhibitory peptides.
Burke TR; Ye B; Akamatsu M; Ford H; Yan X; Kole HK; Wolf G; Shoelson SE; Roller PP
J Med Chem; 1996 Mar; 39(5):1021-7. PubMed ID: 8676336
[TBL] [Abstract][Full Text] [Related]
34. Deciphering Phosphotyrosine-Dependent Signaling Networks in Cancer by SH2 Profiling.
Machida K; Khenkhar M; Nollau P
Genes Cancer; 2012 May; 3(5-6):353-61. PubMed ID: 23226573
[TBL] [Abstract][Full Text] [Related]
35. Tyrosine phosphoproteomics and identification of substrates of protein tyrosine phosphatase dPTP61F in Drosophila S2 cells by mass spectrometry-based substrate trapping strategy.
Chang YC; Lin SY; Liang SY; Pan KT; Chou CC; Chen CH; Liao CL; Khoo KH; Meng TC
J Proteome Res; 2008 Mar; 7(3):1055-66. PubMed ID: 18281928
[TBL] [Abstract][Full Text] [Related]
36. Nonphosphorylated peptide ligands for the Grb2 Src homology 2 domain.
Oligino L; Lung FD; Sastry L; Bigelow J; Cao T; Curran M; Burke TR; Wang S; Krag D; Roller PP; King CR
J Biol Chem; 1997 Nov; 272(46):29046-52. PubMed ID: 9360978
[TBL] [Abstract][Full Text] [Related]
37. Optimization of immunoaffinity enrichment and detection: toward a comprehensive characterization of the phosphotyrosine proteome of K562 cells by liquid chromatography-mass spectrometry.
Artemenko KA; Bergström Lind S; Elfineh L; Mayrhofer C; Zubarev RA; Bergquist J; Pettersson U
Analyst; 2011 May; 136(9):1971-8. PubMed ID: 21403953
[TBL] [Abstract][Full Text] [Related]
38. Identification of domains of the v-crk oncogene product sufficient for association with phosphotyrosine-containing proteins.
Matsuda M; Mayer BJ; Hanafusa H
Mol Cell Biol; 1991 Mar; 11(3):1607-13. PubMed ID: 1705010
[TBL] [Abstract][Full Text] [Related]
39. Dissecting the interaction of SHP-2 with PZR, an immunoglobulin family protein containing immunoreceptor tyrosine-based inhibitory motifs.
Zhao R; Zhao ZJ
J Biol Chem; 2000 Feb; 275(8):5453-9. PubMed ID: 10681522
[TBL] [Abstract][Full Text] [Related]
40. Highly robust, automated, and sensitive online TiO2-based phosphoproteomics applied to study endogenous phosphorylation in Drosophila melanogaster.
Pinkse MW; Mohammed S; Gouw JW; van Breukelen B; Vos HR; Heck AJ
J Proteome Res; 2008 Feb; 7(2):687-97. PubMed ID: 18034456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
